Medical Properties Trust just sold two Idaho hospitals for $371 million, and the central question is whether the company traded away more income than it bought itself in relief.

The deal, announced September 16, sent the real estate of Idaho Falls Community Hospital and Mountain View Hospital to affiliates of Intermountain Health for $413 million in total. Medical Properties Trust, known as MPT, received $371 million after $42 million went to minority real estate owners. Management says most of that cash will go toward paying down debt.

Why MPT is selling at all

MPT is a real estate investment trust, meaning it owns hospital buildings and collects rent from the health systems that operate inside them. It does not run hospitals itself. For years, that model looked like a reliable income machine. Then several major tenants ran into financial trouble, occupancy and rent guarantees came under pressure, and MPT found itself with more debt than its shrinking rental income could comfortably support.

The company disclosed in August that it had arranged $2.4 billion in secured notes carrying a 9.25% interest rate, maturing in 2032. That borrowing cost tells you something important: when MPT goes to refinance debt right now, lenders are charging it nearly a dime on every dollar, annually. That makes paying down principal genuinely attractive, because every dollar retired saves roughly nine cents a year in interest.

The trade-off in plain numbers

The Idaho hospitals were sold at what is called a capitalization rate of 6.9%. That is a standard real estate measure: it tells you what the property earns annually as a share of its sale price. Applied to the $413 million gross transaction price, that implies roughly $28.5 million in annual income from those properties. That figure covers the whole deal including minority interests, so MPT's own share of the lost income is somewhat lower. But it is the right order of magnitude for understanding what left the building.

Now compare that to the interest savings. If MPT uses the full $371 million to retire debt priced at 9.25%, it saves roughly $34 million a year in interest. On that math, the swap looks favorable. But management said only a "majority" of proceeds will go to debt reduction, not all of it. And the announcement did not specify which obligations would be retired, what those obligations actually cost, or whether any early repayment penalties apply. Those details matter. The gap between "probably good" and "demonstrably good" lives inside them.

MPT also reported roughly $680 million in total third-quarter cash proceeds, counting the Idaho sale alongside an earlier initial public offering of its Infracore entity and the sale of interests in five Utah hospitals. The company is clearly in liquidation mode on parts of its portfolio, using asset sales to buy itself room to breathe.

What this means beyond the balance sheet

For ordinary Americans, this story is less about MPT's finances than about what it reveals: hospital real estate has become a stress point in the broader healthcare system. When landlords need to sell, and when the buyers set the terms, the hospitals inside those buildings face new ownership structures, new lease arrangements, and occasionally pressure to cut costs. That pressure tends to travel toward staffing and services before it reaches the balance sheet.

MPT's situation also illustrates how expensive refinancing has become for companies that took on debt during the low-rate era of the early 2020s. A 9.25% borrowing rate was almost unthinkable five years ago for a large, publicly traded real estate company. It is now the going price for a company with MPT's risk profile, and that cost is exactly why selling assets, even good ones, can feel like the only viable move.

The company has bought itself time. Whether it bought enough depends on details it has not yet disclosed.